Complement component 3 (C3) as a biomarker for insulin resistance after bariatric surgery

Clin Biochem. 2017 Jun;50(9):529-532. doi: 10.1016/j.clinbiochem.2017.02.006. Epub 2017 Feb 7.

Abstract

Objectives: Since complement system has been recently associated with metabolic and cardiovascular diseases, and closely related to insulin resistance, we investigated the association of plasma complement factor 3 (C3) and factor 4 (C4) with insulin sensibility and weight loss after bariatric surgery.

Methods: Serum levels of C3, C4, total cholesterol, triacylglycerol, HDL-cholesterol, LDL-cholesterol and homeostatic model assessment (HOMA-IR) measurements were assessed in morbidly obese patients before and after bariatric surgery, including a 6-month follow-up period, as well as a comparison with a lean group.

Results: Weight loss decreased body mass index (BMI), serum triacylglycerol, and increased serum HDL-cholesterol and insulin sensitivity, as expected. C3 and C4 were significantly higher in obese individuals when compared to lean subjects (p<0.001). In addition, C3 and C4 positively correlated with BMI and HOMA-IR, however, only C3 were significantly decreased 6months after surgery.

Conclusion: C3 was strongly associated with insulin sensitivity after bariatric surgery.

Keywords: Bariatric surgery; C3, C4 and C3a-desArg; Complement system; Dyslipidemia and cardiovascular disease; Morbid obesity; Type 2 diabetes.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Bariatric Surgery*
  • Biomarkers / blood
  • Body Mass Index
  • Complement C3 / metabolism*
  • Complement C4 / metabolism
  • Female
  • Follow-Up Studies
  • Humans
  • Insulin Resistance*
  • Lipids / blood
  • Male
  • Middle Aged
  • Obesity, Morbid / blood*
  • Obesity, Morbid / surgery*
  • Postoperative Period

Substances

  • Biomarkers
  • Complement C3
  • Complement C4
  • Lipids